Tactile Medical develops pneumatic compression and respiratory therapy devices designed for at-home treatment of lymphedema, lipedema, and chronic venous insufficiency. Founded in Minneapolis in 1995 by a lymphedema therapist seeking to address gaps in patient care, the company has grown to serve millions of Americans through its expanding product portfolio.
The company's core offerings include the Flexitouch Plus system, an advanced pneumatic compression device for treating chronic swelling throughout the head, trunk, and limbs, and the newer Nimbl system. Tactile Medical has also expanded into respiratory therapy with the AffloVest, an airway clearance solution that reflects the company's broadening focus beyond compression devices. These products emphasise at-home therapy, allowing patients greater independence in managing chronic conditions.
Tactile Medical is publicly traded on NASDAQ under the symbol TCMD. The company's technical expertise spans pneumatic compression device design, airway clearance systems, clinical evidence generation for device therapies, and at-home treatment solutions. Its mission centres on enabling patients to manage their conditions independently at home, rather than relying solely on in-clinic treatments.
